Cargando…

Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer

The burden of somatic mutations and neoantigens has been associated with improved survival in cancer treated with immunotherapies, especially non-small cell lung cancer (NSCLC). However, there is uncertainty about their effect on outcome in early-stage untreated cases. We posited that the burden of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dennis, Pham, Nhu-An, Freeman, Timothy M., Raghavan, Vibha, Navab, Roya, Chang, Jonathan, Zhu, Chang-Qi, Ly, Dalam, Tong, Jiefei, Wouters, Bradly G., Pintilie, Melania, Moran, Michael F., Liu, Geoffrey, Shepherd, Frances A., Tsao, Ming-Sound
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678704/ https://www.ncbi.nlm.nih.gov/pubmed/31330989 http://dx.doi.org/10.3390/cancers11071009

Ejemplares similares

Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)
por: Dhont, Ludovic, et al.
Publicado: (2018)

Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma
por: Ly, Dalam, et al.
Publicado: (2021)

Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non–Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion()()
por: Hao, Jing, et al.
Publicado: (2019)

LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
por: Zeltz, Cédric, et al.
Publicado: (2019)

Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts
por: Weiss, Jessica, et al.
Publicado: (2022)

Optimized application of penalized regression methods to diverse genomic data
por: Waldron, Levi, et al.
Publicado: (2011)

Collagen Type XI Inhibits Lung Cancer-Associated Fibroblast Functions and Restrains the Integrin Binding Site Availability on Collagen Type I Matrix
por: Zeltz, Cédric, et al.
Publicado: (2022)

Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
por: Mirhadi, Shideh, et al.
Publicado: (2023)

Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade
por: Fang, Linan, et al.
Publicado: (2019)

Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes
por: Mirhadi, Shideh, et al.
Publicado: (2022)

Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15
por: Yao, Junlin, et al.
Publicado: (2019)

TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer
por: Hai, Josephine, et al.
Publicado: (2017)

Lung cancer in never smokers from the Princess Margaret Cancer Centre
por: Korpanty, Grzegorz J., et al.
Publicado: (2018)

Integrin α11β1 in tumor fibrosis: more than just another cancer-associated fibroblast biomarker?
por: Zeltz, Cédric, et al.
Publicado: (2022)

Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies
por: Starmans, Maud HW, et al.
Publicado: (2012)

Addition of multiple rare SNPs to known common variants improves the association between disease and gene in the Genetic Analysis Workshop 17 data
por: Sykes, Jenna, et al.
Publicado: (2011)

Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
por: Lohse, Ines, et al.
Publicado: (2014)

Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
por: Leung, Lisa, et al.
Publicado: (2012)

p120RasGAP Is a Mediator of Rho Pathway Activation and Tumorigenicity in the DLD1 Colorectal Cancer Cell Line
por: Organ, Shawna L., et al.
Publicado: (2014)

Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers
por: Pham, Nhu-An, et al.
Publicado: (2021)

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma
por: Chung, Catherine T-S, et al.
Publicado: (2010)

Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
por: Lohse, Ines, et al.
Publicado: (2016)

Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients
por: Fung, Andrea S., et al.
Publicado: (2021)

Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis Pathways
por: Reis, Patricia P., et al.
Publicado: (2020)

Cancer proteome and metabolite changes linked to SHMT2
por: Tong, Jiefei, et al.
Publicado: (2020)

MATE2 Expression Is Associated with Cancer Cell Response to Metformin
por: Chowdhury, Sanjana, et al.
Publicado: (2016)

A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196
por: Leighl, Natasha B., et al.
Publicado: (2017)

Unsupervised determination of lung tumor margin with widefield polarimetric second-harmonic generation microscopy
por: Mirsanaye, Kamdin, et al.
Publicado: (2022)

Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor suppressive role in pancreatic ductal adenocarcinoma
por: Radulovich, Nikolina, et al.
Publicado: (2014)

Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors
por: Brenner, Darren R, et al.
Publicado: (2010)

Transcriptome Profiles of Carcinoma-in-Situ and Invasive Non-Small Cell Lung Cancer as Revealed by SAGE
por: Lonergan, Kim M., et al.
Publicado: (2010)

The non-random landscape of somatically-acquired uniparental disomy in cancer
por: Erola, Pau, et al.
Publicado: (2019)

Somatic genetic variation in healthy tissue and non-cancer diseases
por: Solís-Moruno, Manuel, et al.
Publicado: (2022)

A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer
por: Sacher, Adrian G., et al.
Publicado: (2016)

Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer
por: Navab, R, et al.
Publicado: (2016)

Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis
por: Pham, Nhu-An, et al.
Publicado: (2008)

Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas
por: Siddiqui, Iram, et al.
Publicado: (2022)

Patient-derived cell line, xenograft and organoid models in lung cancer therapy
por: Huo, Ku-Geng, et al.
Publicado: (2020)

Ancillary Testing in Lung Cancer Diagnosis
por: Dubinski, William, et al.
Publicado: (2012)

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
por: Melosky, Barbara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dlo505kup8m4idjb1kmjo67emb